Fennec Pharmaceuticals Inc
|Market Cap (Intraday)||250.57M|
|2yr Forward PE||N/A|
Fennec Pharmaceuticals Inc Stock, NASDAQ:FENC
Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.